Yasuhiro Hashimoto

About

Dr. Yasuhiro Hashimoto is a leading urologic oncologist whose research bridges surgical innovation and geriatric oncology, with a particular focus on prostate and bladder cancers. His work has fundamentally advanced the understanding of how frailty—measured by the Geriatric 8 (G8) screening tool—impacts treatment decisions and outcomes. Through landmark prospective studies, including the FRART-PC and FRAP studies, Dr. Hashimoto demonstrated that frailty is a critical predictor of surgical contraindication and post-operative pain, with his 2020 paper on G8 screening in prostate cancer accumulating 40 citations. He is also a pioneer in minimally invasive surgery, having developed the robotic cross-folded U-configuration intracorporeal ileal neobladder for muscle-invasive bladder cancer (31 citations) and extensively studied robot-assisted radical prostatectomy outcomes in elderly patients. His research portfolio, spanning over 150 citations, consistently shows that geriatric assessment should guide urologic cancer care. Notably, he has also explored innovative biomarkers like total cell-free DNA for evaluating surgical damage. Dr. Hashimoto’s work is essential reading for any clinician or researcher seeking to optimize surgical outcomes in the growing population of older cancer patients.

Research Focus

Key Achievements

Top Papers

1. 1
   Geriatric 8 screening of frailty in patients with prostate cancer

   40 citations · 2020
2. 2
   Robotic cross-folded U-configuration intracorporeal ileal neobladder for muscle-invasive bladder cancer: Initial experience and functional outcomes

   31 citations · 2018
3. 3
   Effect of frailty and comorbidity on surgical contraindication in patients with localized prostate cancer (FRART-PC Study)

   19 citations · 2020
4. 4
   Frailty is a predictor of moderate to severe pain after robot‐assisted laparoscopic prostatectomy: A case‐control study (FRAP study)

   17 citations · 2020
5. 5
   Minimum incision endoscopic radical prostatectomy: Clinical and oncological outcomes at a single institute

   16 citations · 2011
6. 6
   Oncologic and patient-reported outcomes after robot-assisted radical prostatectomy in men aged ≥75 years

   14 citations · 2021
7. 7
   Utility of total cell-free DNA levels for surgical damage evaluation in patients with urological surgeries

   13 citations · 2021
8. 8
   Neoadjuvant chemohormonal therapy followed by robot-assisted and minimum incision endoscopic radical prostatectomy in patients with high-risk prostate cancer: comparison of perioperative and oncological outcomes at single institution

   13 citations · 2018
9. 9
   The feasibility and effectiveness of robot-assisted radical cystectomy after neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer

   12 citations · 2016
10. 10
    The effect of frailty on the quality of life and lower urinary symptoms following robot-assisted radical prostatectomy: A longitudinal analysis (FRARP-QL Study)

    12 citations · 2020

Key Collaborators

Contact & Links